Budesonide and Surfactant Combination for Treatment of Respiratory Distress Syndrome in Preterm Neonates and Evaluation Outcomes
Journal of Clinical Neonatology · 2023-10 · 12 (4) · 135-141
DOI: 10.4103/jcn.jcn_52_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Neonatology, online erschienen am 21.12.2023. Verfasst von Fatemeh Baghal Safa und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Pulmonary inflammation plays a critical role in the pathogenesis of respiratory distress syndrome. The aim of this study was to compare the effectiveness of intratracheal administration combination of pulmonary surfactant (PS) and budesonide with surfactant alone in preterm neonates. Materials and Methods: This randomized clinical trial was performed in Yazd between 2020 and 2022. A total of 70 preterm neonates weighing between 800 and 1500 g were included in the study.
Results
The risk of bronchopulmonary dysplasia (BPD) in infants treated with PS and budesonide was seven times lower than in the surfactant group alone ( P = 0.004). Furthermore, in the intervention group, the hospitalization period ( P = 0.004) and retinopathy of prematurity ( P = 0.02) were significantly reduced.
Conclusion
In these neonates, intratracheal administration of surfactant/budesonide combination significantly decreases the incidence of frequent apnea, BPD, continuous positive airway pressure therapy, and earlier discharge. There is a need for larger trials and an exact evaluation of side effects.
Zitieren
APA
Safa, F. B., Noorishadkam, M., Lookzadeh, M. H., Mirjalili, S. R., & Ekraminasab, S. (2023). Budesonide and Surfactant Combination for Treatment of Respiratory Distress Syndrome in Preterm Neonates and Evaluation Outcomes. Journal of Clinical Neonatology, 12(4), 135-141. https://doi.org/10.4103/jcn.jcn_52_23
Vancouver
Safa FB, Noorishadkam M, Lookzadeh MH, Mirjalili SR, Ekraminasab S. Budesonide and Surfactant Combination for Treatment of Respiratory Distress Syndrome in Preterm Neonates and Evaluation Outcomes. Journal of Clinical Neonatology. 2023;12(4):135-141. doi:10.4103/jcn.jcn_52_23
BibTeX
@article{Safa2023,
author = {Safa, Fatemeh Baghal and Noorishadkam, Mahmood and Lookzadeh, Mohamad Hosein and Mirjalili, Seyed Reza and Ekraminasab, Sedigheh},
title = {Budesonide and Surfactant Combination for Treatment of Respiratory Distress Syndrome in Preterm Neonates and Evaluation Outcomes},
journal = {Journal of Clinical Neonatology},
year = {2023},
volume = {12},
number = {4},
pages = {135--141},
doi = {10.4103/jcn.jcn_52_23}
}
EUVIMED